Utkrisht Suri
Healthcare-focused investment professional with ~4 years of experience across growth investing, equity research, and M&A advisory. At Fidelity International's Eight Roads Research Team, I contributed to a US$15M Series A investment in Laurus Bio by leading expert outreach and financial due diligence, and evaluated Toothsi's merger with Singapore-based Zenyum across Asia-Pacific dental markets. Previously at RocSearch India, I initiated equity research coverage of ASX and European small caps and delivered M&A advisory that drove a 30% revenue uplift for a UK-based client. Having cleared CFA Levels I & II on the first attempt, both above the 90th percentile, I bring a strong foundation of financial rigour to every engagement. Currently pursuing my MBA at XLRI Jamshedpur, where I am spearheading initiatives across the Conclave and Finance committees.
Work experience
44 months in total
- RocSearch India24 months
Career highlights
Senior Associate PE/VC Research
- NEW INVESTMENTS:
- Conducted diligence for a US$15M series A investment in Laurus Bio, a precision fermentation-based CDMO for the food and personal care industries, identifying a whitespace for outsourced synthetic biology manufacturing capacity
- Led calls with 10+ synthetic biology experts, validating the investment thesis; Introduced the company to 5 potential customers; Built a financial model outlining economics for 2x capacity expansion
- PORTFOLIO MANAGEMENT:
- Formulated thesis for Toothsi’s acquisition of Zenyum, sizing the dental aligner market in Singapore, Taiwan and Vietnam
- Conducted a detailed customer insight analysis using online aggregators like Lazada, Amazon, etc., deriving customer satisfaction ratings for Zenyum’s products
- SECTOR COVERAGE:
- Created a founder analysis framework by analysing the 150 most profitable healthcare exits in the last decade, helping senior management to assess fundamental drivers of successful exits
- Automated a 150+ healthcare-focused public market database, reducing data populating time by c.50%
Senior Analyst, Investment Research
- EQUITY RESEARCH:
- Provided sell-side equity research services to small-cap companies based out of Australia and Europe, initiating and updating coverage on Amplia Therapeutics (EV: A$50M), Elixir Energy (EV: A$250M), and Drone Volt SA (EV: U$50.7M)
- Prepared three-statement financial models, forecasting key financials and conducting discounted cash flow valuation, relative valuation and sum-of-the-parts (SOTP) valuations for globally listed companies
- MERGERS & ACQUISITIONS:
- Streamlined the topline of a UK-based precious metal wholesaler by reducing clients’ exposure to volatile commodities and diversifying its revenue streams, thereby increasing the client’s revenue by 30%
- Provided buy-side advisory to a Europe-based oil & gas player by developing a potential list of synergy-driven acquisition targets, resulting in a decrease in the client’s extraction cost by 10%
Achievements
- Promotion to Senior Analyst, Investment Research & Advisory (within one year; average period: 2 years)
- Institutional rank - 1, B.A (Hons) Economics, College of Vocational Studies
- Gold medal, International Maths Olympiad; Bronze Medal, International Economics Olympiad
Certifications
- CFA Level II (score above 90th percentile)
- CFA Level I (score above 90th percentile)
